Detalhe da pesquisa
1.
The ubiquitin-modifying enzyme A20 restricts ubiquitination of the kinase RIPK3 and protects cells from necroptosis.
Nat Immunol
; 16(6): 618-27, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25939025
2.
Erratum: The ubiquitin-modifying enzyme A20 restricts ubiquitination of the kinase RIPK3 and protects cells from necroptosis.
Nat Immunol
; 16(7): 785, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26086145
3.
Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2.
Proc Natl Acad Sci U S A
; 113(17): 4777-82, 2016 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-27078105
4.
Liver-specific Fas silencing prevents galactosamine/lipopolysaccharide-induced liver injury.
Apoptosis
; 20(4): 500-11, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25601293
5.
Aquaporin 4-specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize Clostridium ABC transporter.
Ann Neurol
; 72(1): 53-64, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22807325
6.
Long-term real-world effectiveness and safety of fingolimod over 5 years in Germany.
J Neurol
; 269(6): 3276-3285, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34982201
7.
MAPK3 deficiency drives autoimmunity via DC arming.
Eur J Immunol
; 40(5): 1486-95, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20186879
8.
The Change of Fingolimod Patient Profiles over Time: A Descriptive Analysis of Two Non-Interventional Studies PANGAEA and PANGAEA 2.0.
J Pers Med
; 11(6)2021 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34208513
9.
Descriptive Analysis of Real-World Data on Fingolimod Long-Term Treatment of Young Adult RRMS Patients.
Front Neurol
; 12: 637107, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33763018
10.
TRAIL limits excessive host immune responses in bacterial meningitis.
J Clin Invest
; 117(7): 2004-13, 2007 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-17571163
11.
Differential immune cell dynamics in the CNS cause CD4+ T cell compartmentalization.
Brain
; 132(Pt 5): 1247-58, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19179377
12.
Neuronal damage in autoimmune neuroinflammation mediated by the death ligand TRAIL.
Neuron
; 46(3): 421-32, 2005 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-15882642
13.
The role of TRAIL/TRAIL receptors in central nervous system pathology.
Front Biosci
; 12: 2912-21, 2007 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17485268
14.
Treatment of spontaneous EAE by laquinimod reduces Tfh, B cell aggregates, and disease progression.
Neurol Neuroimmunol Neuroinflamm
; 3(5): e272, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27704036
15.
Glatiramer acetate treatment negatively regulates type I interferon signaling.
Neurol Neuroimmunol Neuroinflamm
; 2(6): e179, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26601118
16.
Laquinimod, an up-and-coming immunomodulatory agent for treatment of multiple sclerosis.
Exp Neurol
; 262 Pt A: 66-71, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24731945
17.
MOG transmembrane and cytoplasmic domains contain highly stimulatory T-cell epitopes in MS.
Neurol Neuroimmunol Neuroinflamm
; 1(2): e20, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25340072
18.
Immunodominant T-cell epitopes of MOG reside in its transmembrane and cytoplasmic domains in EAE.
Neurol Neuroimmunol Neuroinflamm
; 1(2): e22, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25340074
19.
Tob1 plays a critical role in the activation of encephalitogenic T cells in CNS autoimmunity.
J Exp Med
; 210(7): 1301-9, 2013 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23797093
20.
MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies.
J Exp Med
; 210(13): 2921-37, 2013 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-24323356